EU CPI Fundamentals Update as at 26 November 2013 by Lorenzo Beriozza October HICP inflation was the lowest in four years. On a quarterly basis, it looks as if price levels will fall in Q4. Declines are rare and usually followed by a reversal the following quarter. Overall, we do not think the factors that [...]
The US Fed in October Fundamentals Update as at 25 November 2013 by Lorenzo Beriozza Tapering of asset purchases could begin “in coming months” cried the minutes of the Fed’s October policy meeting. But the other message that rings loud and clear from both the minutes and recent remarks by Bernanke and Yellen is that [...]
US Consumer Price Index Fundamentals Update as at 21 November 2013 by Lorenzo Beriozza The Consumer Price Index (CPI) fell by 0.06% in October from the month prior surprising to the downside with economists expecting a flat reading. The YoY advance slowed to just 0.96% -- its lowest level in four years. Core CPI inflation [...]
Japan Inflation Fundamentals Update as at 20 November 2013 by Lorenzo Beriozza Upward pressures on CPI from energy inflation have started to soften, suggesting that the YoY CPI inflation rate should soften around the end of this year despite continuing modest price hikes for food products. Wage-related indicators remain sluggish. Without a material rise in [...]
UK Interest Rates Fundamentals Update as at 19 November 2013 by Lorenzo Beriozza The Bank of England (BoE) voted unanimously (9-0) to leave interest rates and QE on hold at 0.5% and £375 billion respectively at their November meeting, in line with market expectations. The broader tone of the debate was also quite balanced, consistent [...]
US Earnings Season Fundamentals Update as at 18 November 2013 by Lorenzo Beriozza Stocks slid lower from mid-September until the earnings season got underway with Alcoa, the company that traditionally marks the start of the reporting season, which released results after the stock market closed on October 8, 2013. The stock market then turned higher [...]
This article features as part of our proprietary research into the effects of the Fiscal Cliff and related budget reduction factors on the US Health Care industry. The US healthcare industry is one of the biggest in terms of expenditure and breadth, and arguably the most complex and challenging both at a macro and micro [...]
This article features as part of our proprietary research into the effects of the Fiscal Cliff and related budget reduction factors on the US Defense industry. Why Raytheon Can Safeguard Your Defense Portfolio Following on from our previous article, "Defense Industry Uncertainty," we would like to focus the attention of an interesting case of company [...]
This article features as part of our proprietary research into the effects of the Fiscal Cliff and related budget reduction factors on the US Health Care industry. 'Tenet-ative' times for one of the largest US Health Care Providers There is currently a trend of consolidation afoot in the U.S. healthcare industry, as companies that are [...]
This article features as part of our proprietary research into the effects of the Fiscal Cliff and related budget reduction factors on the US Defense industry Why Oshkosh (NYSE:OSK) is a top SELL target Here is how the tale goes: you have a company producing different products, for different markets, and for different purposes. But [...]
